Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
Lilly Asia Ventures
About
Lilly Asian Ventures is an investment firm that invests in promising life science companies.
- Shanghai,Shanghai,China
- http://www.lillyasiaventures.com
Details
- Industries
- Biotechnology,Pharmaceutical,Venture Capital
- Founded date
- Jan 1, 2008
- Operating Status
- Active
- Also Known As
- 礼来亚洲基金,Lilai Yazhou Jijin
- Investor Type
- Venture Capital
Lilly Asian Ventures makes venture capital investments in Asia for Eli Lilly and Company, a global innovation-driven pharmaceutical company. Lilly Asian Ventures invests in promising life science companies with strong management teams and innovative technology and/or business models. Their initial focus will be primarily on opportunities in China, although they will consider investment opportunities elsewhere in east and south Asia.
Funds Raised
| Announced Date | Fund Name | Money Raised | |
|---|---|---|---|
| Feb 14, 2019 | LAV Biosciences Fund V | $40M | |
| Aug 13, 2017 | LAV Biosciences Fund IV | $450M |
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jan 20, 2023
ADARx Pharmaceuticals
|
Series B | $46M | Biotechnology | — |
|
Dec 21, 2022
|
Series B | — | Health Care | — |
|
Dec 9, 2022
|
Series A | $40M | Manufacturing | — |
|
Nov 29, 2022
Rgenta Therapeutics
|
Series A | $52M | Biotechnology | — |
|
Nov 11, 2022
Pulnovo Medical
|
Series Unknown | — | Health Care | — |
Employee Profiles
Exits
Lilly Asia Ventures has had 38 exits. Lilly Asia Ventures most notable exits include Structure Therapeutics , Tmunity Therapeutics
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Feb 2, 2023 | Structure Therapeutics | IPO | Biotechnology | Detail |
| Dec 20, 2022 | Tmunity Therapeutics | M&A | Biotechnology | Detail |
| Jul 24, 2022 | InventisBio | IPO | Biopharma | Detail |
| Apr 1, 2022 | Remegen | IPO | Biotechnology | Detail |
| Mar 29, 2022 | Veritas Genetics | M&A | Biotechnology | Detail |
